Australia Reports Success On New-Generation Cochlear Implant
This article was originally published in PharmAsia News
Australian researchers unveiled a newly developed bionic cochlear ear implant that relies on electrode fibers to stimulate hearing in the profoundly deaf. The new device is a multi-channel implant believed the first to provide speech understanding to that group and to children born deaf. The lead researcher said he hoped to have test results for the "hi-fi" ear available in five years. (Click here for more
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.